CURE10h
FDA Approves Initiation of a New Trial in Recurrent Glioblastoma
The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...
Alpha Tau receives FDA approval to start trial for patients with recurrent GBM
Medical announced that the FDA has approved an Investigational Device Exemption, IDE, application to initiate a pilot study ...
Medical Device Network on MSN1d
FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout
The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.
Drug Delivery Business1d
Glucotrack expects FDA IDE for implantable CBGM this year
Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...
JointMedica Announces Launch of IDE Study for Polymotion® Hip Resurfacing System
JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study ...
MyChesCo on MSN18h
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its financial results for 2024, alongside major ...
Crain's Chicago Business6d
Abbott's new AFib device gets early OK from European regulators
The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...
Crain's Chicago Business9d
Abbott gets green light for clinical trials of new heart treatment system
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, announced today that the FDA has approved an Investigational Device Exemption ...